Table 3. Clinical characteristics of patients with or without endometrial polyps.
Variable | Polyp (n=50) | Non-polyp (n=70) | P-value |
---|---|---|---|
Age (yr) | 44.2±4.1 | 44.0±5.4 | 0.621 |
BMI (kg/m2) | 21.8±5.8 | 22.9±5.3 | 0.894 |
TMX duration (yr) | 2 (0–10) | 3 (0–8) | 0.319 |
Stage | 0.644 | ||
0, I | 32 (64.0) | 38 (54.3) | |
II, III | 18 (36.0) | 32 (45.7) | |
Tumour size (cm) | 0.711 | ||
<2 | 27 (54.0) | 34 (48.6) | |
≥2 | 23 (46.0) | 36 (51.4) | |
Presence of menstruation | 29 (58.0) | 33 (47.1) | 0.270 |
Presence of symptom (AUB) | 5 (10.0) | 25 (35.7) | 0.001 |
EM thickness (mm) | 11.9±4.8 | 10.7±5.2 | 0.142 |
Values are presented as mean±standard deviation, median (range), or number (%).
BMI, body mass index; TMX, tamoxifen; AUB, abnormal uterine bleeding; EM, endometrial.